TipRanks
Go Ultimate55% OFF

Heron Therapeutics (0J4V) Share Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

0J4V Analyst Ratings

Hold
2Ratings
0Buy2Hold0Sell
Based on 2 analysts giving stock ratings to Heron Therapeutics in the past 3 months

0J4V Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GB:0J4V
Price TargetFollowArticle
H.C. Wainwright―hold―Downgraded08/17/26
Needham―hold―Reiterated08/10/26
Northland Securities$4buy1313.43%UpsideReiterated11/05/25
Jefferies$5buy1666.78%UpsideReiterated11/04/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ORKAOruka Therapeutics
ACHVAchieve Life Sciences
OVIDOvid Therapeutics
ZYMEZymeworks
CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Heron Therapeutics

3 Months
Carl Byrnes
Carl ByrnesNorthland Securities
Success Rate15/31 ratings generated profit
48%
Average Return
+1.37%

Copying Carl Byrnes's trades and holding each position for 3 Months would result in 48.39% of your transactions generating a profit, with an average return of +1.37% per trade.

1 Year
Carl Byrnes
Carl ByrnesNorthland Securities
Success Rate4/31 ratings generated profit
13%
Average Return
-29.14%

Copying Carl Byrnes's trades and holding each position for 1 Year would result in 12.90% of your transactions generating a profit, with an average return of -29.14% per trade.

2 Years
Carl Byrnes
Carl ByrnesNorthland Securities
Success Rate2/31 ratings generated profit
6%
Average Return
-58.83%

Copying Carl Byrnes's trades and holding each position for 2 Years would result in 6.45% of your transactions generating a profit, with an average return of -58.83% per trade.

0J4V Analyst Recommendation Trends

02468Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 0J4V
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy64200
Buy00000
Hold11433
Sell00000
Strong Sell00000
total75633

In the current month, 0J4V has received 0 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 0J4V average Analyst price target in the past 3 months is ―.

0J4V Financial Forecast

$-2$-1.5$-1$-0.5$0Q4 2025Q2 2026Q3 2026
High$-0.02
Consensus$-0.03
Low$-0.03

0J4V Earnings Forecast

Next quarter’s earnings estimate for 0J4V is -$0.03 with a range of -$0.03 to -$0.02. The previous quarter’s EPS was -$0.03. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$34.7M$36.2M$37.6M$39.1M$40.6MQ4 2025Q2 2026Q3 2026
High$37.6M
Consensus$37.5M
Low$37.4M

0J4V Sales Forecast

Next quarter’s sales forecast for 0J4V is $37.50M with a range of $37.40M to $37.60M. The previous quarter’s sales results were $37.67M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

0J4V Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Heron Therapeutics a Buy, Sell or Hold?
Heron Therapeutics has a consensus rating of Hold, which is based on 0 buy ratings, 2 hold ratings and 0 sell ratings.
What do analysts say about Heron Therapeutics?
Heron Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of Heron Therapeutics?
To buy shares of GB:0J4V, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.